Guermazi A
Department of Radiology Saint-Louis University Hospital, Paris, France.
Leuk Lymphoma. 2001 Aug;42(4):655-60. doi: 10.3109/10428190109099326.
We believe that lymphography and CT are complementary rather than mutually exclusive techniques for the diagnosis and staging of HD. Unfortunately, it seems that many radiologists and clinicians disregard the ability of lymphography to provide qualitative information on lymph node architecture, which is not available by CT. The use of lymphography is declining in several teaching centers throughout the world. This makes it difficult for young radiologists to acquire the skills needed to perform and interpret lymphographies successfully. In turn, radiologists who have little experience with lymphography are less likely to use the technique. Because most of the treatment-related morbidity in HD is dose-related, and because lymphography helps to avoid over- and undertreatment, we believe that high-quality lymphography continues to have a significant role in the staging of selected HD patients. Moreover. lymphography may reduce both the cost of management and the morbidity rate in many HD patients. One solution would be to continue to use lymphography in a small number of institutions specialized in the management of HD.
我们认为,淋巴造影术和CT在霍奇金淋巴瘤(HD)的诊断和分期中是互补的技术,而非相互排斥。不幸的是,似乎许多放射科医生和临床医生忽视了淋巴造影术提供关于淋巴结结构定性信息的能力,而CT无法提供此类信息。在世界各地的几个教学中心,淋巴造影术的使用正在减少。这使得年轻的放射科医生难以获得成功进行和解读淋巴造影所需的技能。反过来,对淋巴造影术经验不足的放射科医生使用该技术的可能性较小。由于HD中大多数与治疗相关的发病率与剂量相关,且淋巴造影有助于避免过度治疗和治疗不足,我们认为高质量的淋巴造影术在选定的HD患者分期中仍将发挥重要作用。此外,淋巴造影术可能会降低许多HD患者的管理成本和发病率。一种解决方案是在少数专门管理HD的机构中继续使用淋巴造影术。